Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during January 2026'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted a routine regulatory update to the stock exchange reporting the number of shares that were converted from physical form to electronic (demat) form during January 2026. Dematerialization is a standard process where shareholders move their physical share certificates into electronic holdings with a depository. The filing is a monthly compliance requirement and does not indicate any new issuance, buyback, or change in share capital. No specific number of shares or ISIN-level breakup has been disclosed in the headline.
This is a routine procedural disclosure with no direct impact on share price, company fundamentals, or shareholder value. Investors should view it as an administrative update only.